At 35, Katie Dutton is already a rectal cancer survivor, an ordeal that started with seemingly benign symptoms doctors ...

Presented positive initial data from Phase 1 multi-center clinical trial of IMPT-314 in patients with aggressive LBCL in the ...

A medical test used to detect cancer may actually be contributing to the disease because of high amounts of radiation ...

Tumor-infiltrating neutrophils can have either ... Recent discoveries in the field of large extracellular vesicles have revealed a greater diversity in subtypes than was appreciated even only ...

Matthew Matasar, MD, discussed what the findings from the ELM-1 trial of odronextamab in diffuse large B-cell lymphoma mean ...

The panelist discusses how for patients initially eligible for embolization, systemic therapy may be combined with ...

For months, Ash, 26, could hardly eat and felt so exhausted she could hardly work, so she knew it had to be more than regular bloating.

Research by UMass Chan Medical School scientists Sharon Cantor, PhD, and Jenna M. Whalen, PhD, poses a new explanation for how cancer-fighting drugs attack and destroy BRCA1 and BRCA2 tumor cells.

Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape. CS5001 is also being ...

An exclusive video recently obtained by the Global Times clearly shows extensive burn marks on a grounded Philippine military ...